Accretion Pharmaceuticals (NSE:ACCPL) Construction In Progress: ₹2.0 Mil (As of Mar. 2026)


NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
18 GF Score
Price ₹149.15
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Construction In Progress?

Accretion Pharmaceuticals NSE:ACCPL -1.81% 18 Construction In Progress is ₹2.0 Mil as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Accretion Pharmaceuticals's quarterly construction in progress stayed the same from Mar. 2025 (₹0.0 Mil) to Sep. 2025 (₹0.0 Mil) but then increased from Sep. 2025 (₹0.0 Mil) to Mar. 2026 (₹2.0 Mil).

Accretion Pharmaceuticals's annual construction in progress stayed the same from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.0 Mil) but then increased from Mar. 2025 (₹0.0 Mil) to Mar. 2026 (₹2.0 Mil).

Accretion Pharmaceuticals Construction In Progress Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Construction In Progress Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
0.00 0.00 0.00 0.00 2.02

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Construction In Progress Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 2.02
NSE:ACCPL
18GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹2.0 Mil mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Construction In Progress of ₹2.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' Construction In Progress too high?
Accretion Pharmaceuticals' current Construction In Progress is ₹2.0 Mil. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Construction In Progress compare to LLY and JNJ?
Accretion Pharmaceuticals' Construction In Progress of ₹2.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Construction In Progress is ₹2.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Construction In Progress of ₹2.0 Mil. The current Construction In Progress is ₹2.0 Mil. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Construction In Progress is ₹2.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score

Get the complete analysis for NSE:ACCPL

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹149.15
Price